| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.6 | 0.0008 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.62 | 0.0008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |